RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR

被引：0
|
作者：
Liu, Joanne [1 ]
Vutien, Philip [2 ]
Huang, Daniel [3 ,4 ]
Ishigami, Masatoshi [5 ]
Daniel, Peter Chen Yang Nikhil [6 ]
Ito, Takanori [5 ]
Dang, Hansen [7 ]
Maeda, Mayumi [7 ]
Leong, Jennifer [8 ]
Landis, Charles [9 ]
Nguyen, Mindie H. [7 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[5] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi, Japan
[6] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[7] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[8] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[9] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
802
引用
收藏
页码：492A / 493A
页数：2
相关论文
共 50 条
  • [31] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [32] Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis
    Liu, Zekun
    Zhao, Zhenzhen
    Ma, Xuefeng
    Liu, Shousheng
    Xin, Yongning
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [33] Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis
    Ma, Xuefeng
    Liu, Shousheng
    Wang, Mengke
    Wang, Yifen
    Du, Shuixian
    Xin, Yongning
    Xuan, Shiying
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 335 - 344
  • [34] Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
    Gupta, Samir K.
    Post, Frank A.
    Arribas, Jose R.
    Eron, Joseph J., Jr.
    Wohl, David A.
    Clarke, Amanda E.
    Sax, Paul E.
    Stellbrink, Hans-Juergen
    Esser, Stefan
    Pozniak, Anton L.
    Podzamczer, Daniel
    Waters, Laura
    Orkin, Chloe
    Rockstroh, Juergen K.
    Mudrikova, Tatiana
    Negredo, Eugenia
    Elion, Richard A.
    Guo, Susan
    Zhong, Lijie
    Carter, Christoph
    Martin, Hal
    Brainard, Diana
    SenGupta, Devi
    Das, Moupali
    AIDS, 2019, 33 (09) : 1455 - 1465
  • [35] Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis
    Zekun Liu
    Zhenzhen Zhao
    Xuefeng Ma
    Shousheng Liu
    Yongning Xin
    BMC Gastroenterology, 23
  • [36] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE: ASSESSING THE CHANGE IN RENAL FUNCTION IN HEPATITIS B PATIENTS
    Lee, Minna
    Lee, Susan M. K.
    Bernstein, David Eric
    HEPATOLOGY, 2019, 70 : 316A - 316A
  • [37] Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation
    Cheng, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1037 - 1037
  • [38] Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir
    Trinh, Sam
    Le, An K.
    Chang, Ellen T.
    Hoang, Joseph
    Jeong, Donghak
    Chung, Mimi
    Lee, Mei-Hsuan
    Wang, Uerica
    Henry, Linda
    Cheung, Ramsey
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 948 - +
  • [39] Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes
    Chen, Huey-Ling
    Lee, Chien-Nan
    Chang, Chin-Hao
    Lai, Ming-Wei
    Tsai, Ming-Chieh
    Mu, Shu-Chi
    Liu, Chun-Jen
    Shih, Jin-Chung
    Wen, Wan-Hsin
    Hu, Rui-Ting
    Huang, Chun-Pin
    Hu, Kuang-Chun
    Chen, Chie-Pein
    Lee, Chyi-Long
    Chien, Rong-Nan
    Chang, Kai-Chi
    Hsu, Hong-Yuan
    Lee, Chien-Chang
    Ni, Yen-Hsuan
    Chang, Mei-Hwei
    LIVER INTERNATIONAL, 2024, 44 (06) : 1422 - 1434
  • [40] Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
    Sinakos, Emmanouil
    Kachru, Nandita
    Tsoulas, Christos
    Jeyakumar, Sushanth
    Smith, Nathaniel J.
    Yehoshua, Alon
    Cholongitas, Evangelos
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (04) : e230090
12345